BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Opexa Therapeutics 

2635 N. Crescent Ridge Drive

The Woodlands  Texas  77381  U.S.A.
Phone: 281-272-9331 Fax: 281-272-1088


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Cell Therapy





 Company News
Opexa Therapeutics (OPXA) Appoints Prof. Hans-Peter Hartung And Timothy Barabe To The Board Of Directors 3/20/2014 6:39:16 AM    More...
Opexa Therapeutics (OPXA) Reports Year End 2013 Financial Results And Provides Corporate Update 2/28/2014 7:19:22 AM    More...
Opexa Therapeutics (OPXA) CEO To Present At The 2014 Leerink Swann and Company Global Healthcare Conference 2/12/2014 9:00:20 AM    More...
Opexa Therapeutics (OPXA) To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 1/29/2014 7:55:36 AM    More...
Opexa Therapeutics (OPXA) Chief Scientific Officer Invited As Guest Speaker At The Phacilitate Cell & Gene Therapy Forum 1/23/2014 9:19:51 AM    More...
Opexa Therapeutics (OPXA) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 12/23/2013 9:30:39 AM    More...
Opexa Therapeutics (OPXA) Provides MS Trial Enrollment Update; 70% Of Patients Enrolled 12/16/2013 9:31:56 AM    More...
Opexa Therapeutics (OPXA) Selected As A “Top 10 Advanced Therapy Projects To Watch” 11/12/2013 9:15:00 AM    More...
Opexa Therapeutics (OPXA) CEO Invited to Join Personalized Medicine Panel at New York CEO Conference 11/8/2013 8:07:12 AM    More...
Opexa Therapeutics (OPXA) Reports Third Quarter 2013 Financial Results and Provides Corporate Update 11/8/2013 7:45:14 AM    More...
12345678910...